At its February meeting, the ACR board of directors approved the Model Biologics Policy, which will be used when discussing guidelines and patients’ quality of treatment with health insurance companies.
Ethics Forum: Understanding the Challenges in Rheumatology Today
Understand the challenges in rheumatology today
Rheumatology Guy
Sung to the Tune of “American Pie”
Insurer Updates
Policy Changes and IFA Codes
Pearls for Preauthorization: Part Two
Last month’s “Rheumatology Practice Pearls” focused on the denial or return of preauthorization requests because of missing data. This month’s pearls focuses on obtaining authorization for off-label drugs and updating a previous preauthorization.
Advocating for Your Interests in the Health Insurance Marketplace
As healthcare reform ramps up and fists grip tighter around the almighty healthcare dollar, the ACR is moving ahead full force in advocating for your interests in the delivery of healthcare. Through what could be described as “offensive” and “defensive” strategies, the ACR is positioning itself as a visible and active player in the managed care marketplace.
Pearls for Preauthorization
Over the next several months, “From the College” will offer practical tips on improving office management guidelines, putting the latest healthcare information technology to work for you, and coding. This month, “From the College” offers some pearls for preauthorization.
Obama and Clinton at the AMA
Then and now: Déjà vu all over again—toujours?
Five Answers You Won’t Get From Insurance Carriers
Have you ever called a carrier and asked why something was denied? If you work in a rheumatology practice, chances are you have, and you probably hung up feeling even more confused than before you made the call.
The Race Between Senators McCain and Obama
At one time, Senators John McCain and Barack Obama were both considered the underdog choices to receive nominations for the 2008 presidential election.